Patents by Inventor Henry Luke Danahay

Henry Luke Danahay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNAi Inhibition of Alpha-ENaC Expression
    Publication number: 20100210513
    Abstract: The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.
    Type: Application
    Filed: April 30, 2010
    Publication date: August 19, 2010
    Inventors: Gino VAN HEEKE, Emma HICKMAN, Henry Luke DANAHAY, Pamela TAN, Anke GEICK, Hans-Peter VORNLOCHER
  • RNAi Inhibition of Alpha-ENaC Expression
    Publication number: 20100210514
    Abstract: The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.
    Type: Application
    Filed: April 30, 2010
    Publication date: August 19, 2010
    Inventors: Gino VAN HEEKE, Emma HICKMAN, Henry Luke DANAHAY, Pamela TAN, Anke GEICK, Hans-Peter VORNLOCHER
  • RNAi Inhibition of Alpha-ENaC Expression
    Publication number: 20100190714
    Abstract: The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.
    Type: Application
    Filed: January 6, 2010
    Publication date: July 29, 2010
    Inventors: Gino VAN HEEKE, Emma Hickman, Henry Luke Danahay, Pamela Tan, Anke Geick, Hans-Peter Vornlocher
  • RNAi inhibition of alpha-ENaC expression
    Patent number: 7718632
    Abstract: The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.
    Type: Grant
    Filed: June 16, 2008
    Date of Patent: May 18, 2010
    Assignee: Novartis AG
    Inventors: Gino Van Heeke, Emma Hickman, Henry Luke Danahay, Pamela Tan, Anke Geick, Hans-Peter Vornlocher
  • COMBINATIONS OF FORMOTEROL AND FLUTICASONE PROPIONATE FOR ASTHMA
    Publication number: 20100034890
    Abstract: A pharmaceutical composition comprising (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) fluticasone propionate, suitable for use in the treatment of inflammatory or obstructive airways diseases.
    Type: Application
    Filed: October 19, 2009
    Publication date: February 11, 2010
    Inventors: Jeremy Guy Clarke, Henry Luke Danahay, Ian F. Hassan
  • ORGANIC COMPOUNDS
    Publication number: 20090203777
    Abstract: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: April 12, 2006
    Publication date: August 13, 2009
    Inventors: Henry Luke Danahay, Darren Mark Legrand, David C. Tully, Jennifer Leslie Harris, Silvia Heuerding, Dilraj Singh, Janet Catherine Maas, Juergen Roettele, Jean-Louis Reber, Stephanie Monnier
  • RNAi Inhibition of Alpha-ENaC Expression
    Publication number: 20090156529
    Abstract: The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.
    Type: Application
    Filed: June 16, 2008
    Publication date: June 18, 2009
    Inventors: Gino VAN HEEKE, Emma HICKMAN, Henry Luke DANAHAY, Pamela TAN, Anke GEICK, Hans-Peter VORNLOCHER
  • Combinations of formoterol and mometasone furoate for asthma
    Patent number: 7067502
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Grant
    Filed: November 20, 2003
    Date of Patent: June 27, 2006
    Assignee: Novartis AG
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Henry Luke Danahay
  • Combinations of formoterol and mometasone furoate for asthma
    Publication number: 20040105822
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Application
    Filed: November 20, 2003
    Publication date: June 3, 2004
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Henry Luke Danahay
  • Combinations of formoterol and fluticasone propionate for asthma
    Publication number: 20040101487
    Abstract: A pharmaceutical composition comprising (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) fluticasone propionate, suitable for use in the treatment of inflammatory or obstructive airways diseases.
    Type: Application
    Filed: November 20, 2003
    Publication date: May 27, 2004
    Inventors: Jeremy Guy Clarke, Henry Luke Danahay, Ian Francis Hassan
  • Combination of formoterol and mometasone furoate for asthma
    Publication number: 20030050290
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Application
    Filed: October 1, 2002
    Publication date: March 13, 2003
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Henry Luke Danahay
  • Combinations of formoterol and fluticasone proppionate for asthma
    Publication number: 20020103260
    Abstract: A pharmaceutical composition comprising (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) fluticasone propionate, suitable for use in the treatment of inflammatory or obstructive airways diseases.
    Type: Application
    Filed: August 15, 2001
    Publication date: August 1, 2002
    Inventors: Jeremy Guy Clarke, Henry Luke Danahay, Ian Francis Hassan